AC Immune SA logo

AC Immune SA

NASDAQ:ACIU

Overview | Financials
Company Name AC Immune SA
Symbol ACIU
Currency USD
Price 3.11
Market Cap 310,006,044
Dividend Yield 0%
52-week-range 2.25 - 5.14
Industry Biotechnology
Sector Healthcare
CEO Dr. Andrea Pfeifer Ph.D.
Website https://www.acimmune.com

An error occurred while fetching data.

About AC Immune SA

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are

Related Stocks

Precigen, Inc. logo

Precigen, Inc.

PGEN

0.937 USD

ESSA Pharma Inc. logo

ESSA Pharma Inc.

EPIX

5.74 USD

Alpine Immune Sciences, Inc. logo

Alpine Immune Sciences, Inc.

ALPN

64.97 USD

Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc.

TNYA

1.91 USD

AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc.

ANTX

1.08 USD

Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc.

DYN

33.39 USD

Financials

Numbers are in millions USD

Numbers are in millions USD